PHOENIX, Oct. 27, 2023 /PRNewswire/ — Moatable, Inc. (NYSE: MTBL) ("Moatable" or the "Company"), which operates two US-based SaaS businesses, Chime Technologies Inc.© and Trucker Path Inc.©, today announced that Mr. Lin Cong resigned from the Company’s Board of Directors, effective on October 23, 2023. Mr. Cong resigned for personal reasons and not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company’s Board of Directors has approved the appointments of Ms. Rebecca Polak to replace Mr. Lin Cong as director and Mr. Michael Schifsky as interim Chief Financial Officer, effective on October 26, 2023.

Ms. Rebecca Polak has provided strategic leadership and vision for technology start-up companies, focusing on improving go-to-market strategies, customer support, and product offerings. She oversaw the corporate sales team at CarLotz, leading to a substantial increase in consigned cars by corporate consignors year-over-year. Furthermore, Ms. Polak has played an instrumental role in public company boards, serving as the Compensation Committee Chair of RumbleOn (NASDAQ: RMBL) and for AAA Hoosier Motor Club. Ms. Polak’s leadership will be instrumental as she joins the Company’s Board of Directors, taking on the role of chair of the Compensation Committee and serving as a member of the Audit Committee and the Corporate Governance and Nominating Committee.

With a career spanning over three decades, Mr. Schifsky’s career highlights include overseeing SEC, Sarbanes-Oxley, NASDAQ, and NYSE reporting. Mr. Schifsky has held key CFO positions in public and private companies, including his tenure as CFO at Xhibit Corp, a digital marketing and technology development company. Prior to his role at Xhibit, he served as an independent consultant and interim CFO for a range of companies, including Big Bear Mining Company and MD Helicopter. His expertise in SEC reporting and operational management and his proactive management style positions him as a valuable asset to the Company’s leadership team.

"On behalf of the Board of Directors, I would like to express my gratitude to Mr. Cong for his time, dedication, and valuable contribution to Moatable over the years," said Moatable’s Chairman and Chief Executive Officer, Mr. Joseph Chen. "We are pleased to have named Ms. Rebecca Polak to join our Board of Directors and Mr. Michael Schifsky as our interim Chief Financial Officer. Both of them bring a wealth of expertise and experience to our organization."

About Moatable Inc.

Moatable, Inc. (NYSE: MTBL) operates several US-based SaaS businesses including Chime, Inc. and Trucker Path. Moatable’s American depositary shares, each of which currently represents forty-five Class A ordinary shares, trade on NYSE under the symbol "MTBL".

Forward-Looking Statements

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about Moatable’s beliefs and expectations, including statements on making investments and operating businesses that generate long-term returns for investors, and expectations for future growth and innovation are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Moatable’s goals and strategies; Moatable’s future business development, financial condition and results of operations; Moatable’s expectations regarding demand for and market acceptance of its services; Moatable’s plans to enhance user experience, infrastructure and service offerings. Further information regarding these and other risks is included in our annual report on Form 10-K for the year ended December 31, 2022 and other documents filed with the SEC. All information provided in this press release is as of the date of this press release, and Moatable does not undertake any obligation to update any forward-looking statement, except as required under applicable law. 

Source : Moatable Announced Appointment of Director and Interim Chief Financial Officer

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BAODING, China , Oct. 26, 2023 /PRNewswire/ — On October 24th, GWM extended invitations to overseas investors for a unique experience, including test drives of the entire product family, a visit to the technology center in Baoding, and a firsthand look at the rollout of 10,000 GWM HAVAL H6 vehicles destined for the Brazilian market.

This event showcased a range of cutting-edge models, including brand new PHEV and BEV new energy products designed for the Chinese market, the GWM ORA 07, GWM TANK 500, GWM POER Shanhai, GWM TANK 400, GWM HAVAL Menglong, and more. Investors were also provided with special access to explore FTXT, SVOLT, the ecosystem enterprises and the R&D center of GWM .

Investors had the unique opportunity to experience these advanced car models, yet to be released to the market, gaining a profound understanding of the company’s remarkable capabilities. As vital partners in GWM’s development, investors expressed their deep appreciation and confidence in the company’s products, commending its innovative prowess and future potential. GWM is committed to continued collaboration with investors to deliver more new energy products that cater to the specific needs of the market, supporting the success of these products in the fiercely competitive industry.

Positioned as a leader in the electrification era, GWM actively aligns itself with international trends and showcases its competitive edge. The company recognizes that the future of the automotive industry is intricately linked with the principles of sustainable development and environmental protection. Consequently, GWM is resolute in its journey towards new energy, not only to meet future environmental requirements but also to address consumers’ pressing demands for eco-friendly and efficient energy solutions.

GWM is committed to solidifying its leading role in the global automobile market and expanding its footprint in new energy development to countries such as Australia, Brazil, Thailand, Chile, Germany, and more. This strategic expansion highlights the company’s remarkable expertise in the new energy sector and establishes a strong foundation for its sustainable growth in the global market.

GWM’s sales of new energy vehicles continue to surge, with the first three quarters of this year witnessing a remarkable 75.77% year-on-year increase, reaching 170,346 units. This impressive growth reflects the company’s comprehensive foray into the new energy vehicle segment and the market’s enthusiastic endorsement of its products.

GWM acknowledges that investor trust is pivotal to its ongoing success and will work tirelessly to foster closer partnerships with investors in the future, sharing new opportunities and navigating challenges together. The company is confident in the future performance of the global new energy vehicle market and eagerly anticipates collaboratively building a greener and more sustainable future with its valued investors.

CONTACTS:

Tyler Qian
Great Wall Motor Company Limited
Baoding, Hebei Province
Website: www.gwm-global.com
Email: globalpr@gwm.cn

Source : GWM Hosts Exclusive Test Drive with Overseas Investors to Co-create Best Cars for Users

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SYDNEY, Oct. 26, 2023 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, and PSI CRO AG ("PSI"), a global contract research organisation committed to on-time enrollment in radiopharmaceutical clinical trials, have entered into an agreement and have commenced work towards Clarity’s Phase III diagnostic trial of SAR-bisPSMA in prostate cancer participants, CLARIFY (NCT06056830)1.

CLARIFY derives from "Positron Emission Tomography using 64Cu-SAR-bisPSMA in participants with high-risk prostate cancer prior to radical prostatectomy: A prospective, single-arm, multi-centre, blinded-review, Phase III diagnostic performance study". It is a non-randomised, open-label clinical trial in 383 participants.

The aim of the Phase III trial is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect prostate cancer within lymph nodes located in the pelvic region. Evaluation will take place over 2 imaging timepoints, Day 1 (day of administration) and Day 2 (approximately 24 hours post administration). CLARIFY is expected to begin recruitment in late 2023.

Clarity’s Executive Chairperson, Dr Alan Taylor, commented, "We are very excited to move one step closer to initiating our first registrational Phase III trial. With recent positive and valuable guidance from the US FDA in relation to our 64Cu-SAR-bisPSMA program, we look forward to commencing recruitment into the CLARIFY trial shortly and to gathering more data on this next-generation product to confirm the compelling preclinical and clinical trial results to date.

"The positive results from our completed PROPELLER2 trial showed that 64Cu-SAR-bisPSMA is safe and its uptake in PSMA-expressing cancer lesions was significantly higher compared to an approved standard-of-care PSMA imaging agent for prostate cancer in Australia and the US. This may enable diagnosis of additional and smaller lesions, which we observed in our PROPELLER2 trial, and we are eager to investigate the further benefits of delayed imaging, particularly in this patient population, a characteristic not available to the first generation of PSMA diagnostic agents. Furthermore, we believe that the additional shelf-life of up to 48 hours will not only allow clinics greater flexibility in scheduling of the scans, but also improve patients’ access to care in clinics and geographic areas where the short half-life of current PSMA PET tracers restricts the use of radiopharmaceuticals."

PSI’s Senior Director of Operations, Rhonda Critchlow, commented, "Using our global database of over 400 radiopharmaceutical sites, we will be able to identify sites with the best resources and capabilities for the CLARIFY trial. We are excited to begin our collaboration with Clarity and will focus on the startup of high-performing sites to achieve the first patient in, in the shortest time possible. We believe that a myriad of clinical, logistical and manufacturing benefits of Clarity’s Targeted Copper Theranostics platform holds promise of improving treatment outcomes for patients with cancer and look forward to working together on achieving this important goal."

About SAR-bisPSMA

SAR-bisPSMA derives its name from the word "bis", which reflects a novel approach of connecting two PSMA-targeting agents to Clarity’s proprietary sarcophagine (SAR) technology that securely holds copper isotopes inside a cage-like structure, called a chelator. Unlike other commercially available chelators, the SAR technology prevents copper leakage into the body. SAR-bisPSMA is a TCT that can be used with isotopes of copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy.

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA are unregistered products. Individual results may not represent the overall safety and efficacy of the products. The data outlined in this announcement has not been assessed by health authorities such as the US Food and Drug Administration (FDA). A clinical development program is currently underway to assess the efficacy and safety of these products. There is no guarantee that these products will become commercially available.

About Prostate Cancer

Prostate cancer is the second most common cancer diagnosed in men globally and the fifth leading cause of cancer death worldwide3. The American Cancer Institute estimates in 2023 there will be 288,300 new cases of prostate cancer in the US and around 34,700 deaths from the disease4.

About Clarity Pharmaceuticals

Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceuticals, developing targeted copper theranostics based on its SAR Technology Platform for the treatment of cancer in children and adults.

www.claritypharmaceuticals.com

About PSI CRO

PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specialises in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

References

1.   Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study – CLARIFY. ClinicalTrials.gov ID NCT06056830.
2.   Lengyelova E, Wong V, Lenzo N, Parker M, Emmett L. 64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer. ASCO 2023. Poster available at: claritypharmaceuticals.com/pipeline/scientific_presentations
3.   Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660
4.   American Cancer Society: Key Statistics for Prostate Cancer, https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

For more information, please contact:

Clarity Pharmaceuticals

Dr Alan Taylor                                     
Executive Chairman                                           
[email protected]                                    

Catherine Strong
Investor/Media Relations
cstrong@citadelmagnus.com
+61 406 759 268

This announcement has been authorised for release by the Executive Chairman.

Source : Clarity and PSI kick off SAR-bisPSMA Phase III

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ — IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to announce its continued sponsorship of School the World, an organization focused on providing access to quality education in Central America. For the fifth time, IMG will be sending a group of employees on a week-long, corporate service trip to the Western Highlands of Guatemala where they will assist in building a new school for a community in need.

"It has been an amazing tradition for our staff and company to sponsor School the World, and we are proud to send another group of IMG employees to participate in the 2024 corporate service trip," said IMG President and CEO, Steve Paraboschi. "At IMG, our purpose is to be there to protect and enhance the well-being of our customers, and this trip is a great way for our employees to gain a better understanding of what it means to be there for the customers we serve."

The IMG School the World team members were selected based on applications submitted via written essay or video. Submitted applications were carefully reviewed, and seven IMG employees were chosen to embark on the trip of a lifetime.

"I had the honor of helping represent IMG during the 2023 corporate service trip to Guatemala with School the World, and it was truly a life-changing experience," said IMG Public Relations Specialist, Carly Miller. "It was so enlightening to be in a new culture and heartwarming to help build a new school that will have an impact on its community for years to come. I am very grateful to both IMG and School the World for allowing me and my coworkers to have this incredible opportunity."

School the World was founded in 2009 to fight extreme poverty at its core by bringing quality education to children in Guatemala, Honduras, and Panama. Since its founding, the non-profit organization has built more than 125 schools for over 15,000 children. School the World works both on-site in poverty-stricken communities who have little to no access to education, as well as in the U.S., providing students, families, and companies the opportunity to create change.

"We are so grateful that IMG has made the decision to partner with us at School the World for another corporate service trip in 2024," said Kate Curran, Founder and CEO of School the World. "We believe learning and evolving are essential to creating change, and we are on a mission to solve the education crisis in our world. The work we do to affect change wouldn’t be possible without the generosity of corporate partners like IMG, and we cannot wait for our trip to Guatemala together."

The 2024 service trip will take place March 3-9, 2024. For more information about School the World, visit https://schooltheworld.org/.

About IMG® (International Medical Group®)

IMG® (International Medical Group®), a SiriusPoint company, is an award-winning global insurance benefits and assistance services company that has served millions of members worldwide since its founding in 1990. The preeminent provider of travel and health safety solutions, IMG offers a wide range of insurance programs, including international private medical insurance, travel medical insurance, and travel insurance, as well as enterprise services, including insurance administrative services and 24/7 emergency medical, security, and travel assistance. IMG’s world-class services, combined with an extensive product portfolio, provide Global Peace of Mind® for travelers, students, missionaries, marine crews, and other individuals or groups traveling, working, or living away from home. For more information, please visit www.imglobal.com.

About School the World

Our mission is to solve extreme poverty through the power of education. We believe that by working together we can create a world where every child has the quality education they deserve. That is why we work both on the ground in poverty-stricken communities who have little to no access to education, as well as right here in the U.S., providing students, families, and companies the opportunity to create change. Our strategy is to work at the grassroots level, organizing communities around education from early childhood through adolescence. Our Service Program amplifies our impact at home & abroad. Everyone, working together, towards making our world a more just place. Learn more at www.schooltheworld.org.

Source : IMG Continues Partnership with School the World for Fifth Corporate Service Trip

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Memorandum of Understanding to be inked between Lunit and Seha Virtual Hospital, marking a new era in Saudi Arabia’s healthcare innovation movement

SEOUL, South Korea, Oct. 26, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its full-fledged participation in the ‘Saudi Vision 2030’ Healthcare Sandbox. Lunit’s involvement in the Sandbox signifies a broader commitment to advancing the Saudi Arabian healthcare sector.

left to right: Ala’a Nouraldeen Al Khateeb, Director of Medical Devices & Projects Business Unit, Mediserv; JaeMin Oh, VP of Business Development, Lunit; Omar Bin Humid, CEO, Mediserv; Brandon Suh, CEO, Lunit; JoonYong Park, Ambassador, Embassy of the Republic of Korea in Saudi Arabia; Abdulaziz Bin Hamad Romeh, Vice Minister, Ministry of Health Saudi Arabia; Rakan Bin Dohaish, Assistant Deputy Minister, International Collaboration; Mona Subaie, CEO, SVH. Riyadh, Kingdom of Saudi Arabia, Oct. 25

The Healthcare Sandbox, initiated by the Saudi Arabian Ministry of Health in line with the Saudi Vision 2030 strategy, is designed to facilitate the digital transformation of the Kingdom’s healthcare industry. Partners are offered a business-friendly environment that encourages active collaboration with medical institutions nationwide, attracts investment, and opens avenues for business expansion.

As part of the Sandbox, Lunit will immediately sign a Memorandum of Understanding (MoU) with Seha Virtual Hospital (SVH). The collaboration aims to strengthen the partnership and contribute significantly to the Kingdom’s national cancer screening program. The signing ceremony will take place on October 29th in Riyadh, with key dignitaries in attendance, including Brandon Suh, CEO of Lunit, Dr. Mohammed Alhamali, Director of Innovation and Business Development at Seha Virtual Hospital.

Under the MoU, Lunit will provide SVH and its network of approximately 150 connected hospitals with the Lunit INSIGHT suite, an AI-powered solution for timely cancer detection. The initial deployment will start at King Saud Medical City in Riyadh, and Al mashaier hospitals (group of 8 hospitals) in Makkah.

In addition to enabling early-stage cancer screening, the collaboration will also focus on co-developing an AI-based CT analyzer to support more precise cancer and tuberculosis diagnosis. Furthermore, the partnership will actively work to secure high-quality healthcare data, contributing to the ongoing enhancement of Lunit’s AI models.

This project represents a significant advancement over the previous collaboration, initiated in July of this year. During this prior partnership, Lunit and Seha Virtual Hospital commenced delivering and integrating Lunit’s solutions for validation.

Seha Virtual Hospital, the world’s largest virtual hospital, is a key part of the Kingdom’s healthcare transformation initiative, the cornerstone of the Saudi Vision 2030 strategy. SVH provides medical services to approximately 480,000 patients annually, supporting 150 hospitals nationwide.

"Our expanded partnership with the Ministry of Health and Seha Virtual Hospital represents a significant step forward in improving the cancer care efforts in the Kingdom," said Brandon Suh, CEO of Lunit. "By delivering our AI-powered solution, we aim to enable early cancer detection, a pivotal factor in enhancing patient outcomes. Given that Saudi Arabia boasts the largest medical market in the Gulf Cooperation Council, this initiative underscores a meaningful impact on healthcare in the Middle East, and we eagerly anticipate contributing our expertise to this essential endeavor."

According to Business Markets Insights, the medical imaging informatics market in the Middle East and Africa (MEA) was valued at USD 1,607 million in 2021 and is projected to exceed USD 2,046 million by 2028, with an expected CAGR of 3.5% from 2021 to 2028. With Saudi Arabia being the largest market in the MEA, accounting for 22.7%, the collaboration holds immense potential for Lunit’s expansion and impact in the region.

Source : Lunit Participates in Saudi Vision 2030 Healthcare Sandbox, Accelerating Saudi Arabia's Healthcare Transformation

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

PALO ALTO, Calif., Oct. 26, 2023 /PRNewswire/ — Moomoo Technologies Inc. ("MTI") announced today that the company will present at the TradersExpo in Orlando, Florida from Oct. 29 to Oct. 31. The company’s Vice President of Strategy Justin Zacks will discuss zero days to expiration options (0DTE) with professional traders and other attendees onsite.

0DTE options trading has increased in popularity over the last few years and traders are eager to know more about 0DTE options and how they work. Zacks will also discuss current and future options trading trends and how to utilize moomoo App tools to understand the market better.

His presentation slots are 1 p.m. ET on Oct. 29 (Sunday) and 10:30 a.m. ET on Oct. 30 (Monday). Zacks will explain what 0DTE options are, how they work, their history, and their similarities and differences from long-dated options. He will also discuss the risk profiles of 0DTE options as well as the different tools and features investors are currently employing to analyze them.

"Moomoo has a paper trading function that can help test traders’ strategies and help build their confidence. The app’s social and learning activities with advanced tools and features provide free and valuable resources for both beginners and experienced traders to make 0DTE options more accessible," said Zacks.

Other Moomoo employees will be on the exhibition floor at booth 313 to present more functions and product features and welcome attendees who can stop by and ask questions and make comments on its App and product offerings. Moomoo’s participation in the conference follows its attendance at TradersExpo in Las Vegas in April.

It’s important to note that options trading is risky and not appropriate for everyone. It’s also important that investors read the Options Disclosure Document before trading. Options are complex and an investor may quickly lose their entire investment.

About Moomoo 

Moomoo is an investment and trading platform that empowers global investors with pro-grade, easy-to-use tools, data, and insights. It provides users with the necessary information and technology to make more informed investment decisions. Investors have access to advanced charting tools, technical analytics, and in-depth Data. Moomoo grows with its users, cultivating a community where investors share, learn, and grow together in one place. Moomoo provides free access to investment courses, educational materials, and interactive events that any investor, at any level, can gain from. Users can join forum discussions, trending topics, and seminars to better their investment knowledge and insights.

The moomoo app is offered by Moomoo Technologies Inc. ("MTI") a company that is based in Palo Alto, California. The app is used globally in countries including the U.S., Singapore, Australia, Japan, Malaysia and Canada. MTI is not a broker-dealer and does not provide investment advice or recommendations. In the U.S., securities products and services are offered by Moomoo Financial Inc. ("MFI"), an SEC-registered broker-dealer and member FINRA/SIPC. MTI and MFI are indirect, wholly-owned subsidiaries of Futu Holdings Limited (Nasdaq: FUTU). FUTU has won multiple awards internationally, such as Fortune’s 100 Fastest Growing Companies in 2022. Moomoo is not just your investment platform. It is your investment journey.

For more information, please visit moomoo’s official website at www.moomoo.com or feel free to email: [email protected].

Source : Moomoo Discusses 0DTE at the TradersExpo in Orlando, Florida on Oct 29

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

PLANTATION, Fla., Oct. 26, 2023 /PRNewswire/ — Everise, a leading global healthcare services outsourcing company, today announced that it has been Certified™ by Great Place To Work®. This marks the first time Everise has achieved this certification, officially recognizing Everise as a great workplace, with 69% of its employees declaring that it is a great place to work, higher than the U.S. average of 57%.

Everise U.S. is proud to announce that it has been Great Place To Work Certified for the first time.

Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.

According to the Great Place To Work survey conducted with Everise employees, 80% felt that they were given great responsibilities and opportunities to grow. 79% shared that they felt a strong sense of pride when looking at their accomplishments with the company. In addition, 79% confirmed that they felt extremely welcome when joining Everise. To find out more about the survey results, visit this page.

"While we have been recognized many times over the years as a great place to work and employer of choice, I am delighted that this year marks the first time we have earned the Great Place To Work® Certification™. This accomplishment is a resounding endorsement of our commitment to our employees and our people-first culture, where we strive everyday to provide an environment where people can thrive professionally and personally. We believe that happy and fulfilled employees are the foundation of Everise’s success," shared Sudhir Agarwal, Founder & CEO of Everise.

Since its inception in 2016, Everise has grown into a 19,000-strong workforce based across eight markets. The company has consistently strived to put people first and at the heart of its business. To achieve a workplace and culture that values and empowers employees, Everise implemented a comprehensive range of employee engagement, culture-building, and Diversity, Equity and Inclusion programs across its global operations. Over the years, the company has attained numerous industry awards in recognition of its leadership, commitment to innovation and people-centric culture.

"Great Place To Work® Certification™ is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. "By successfully earning this recognition, it is evident that Everise stands out as one of the top companies to work for, providing a great workplace environment for its employees."

According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified great workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work, and are twice as likely to be paid fairly, earn a fair share of the company’s profits and have a fair chance at promotion.

WE’RE HIRING!

Looking to grow your career at a company that puts its people first? Visit our careers page at: https://weareeverise.com/work-for-us/

About Everise

Founded in 2016, Everise is a global leader transforming customer service for healthcare, transport, logistics, insurance, financial services, and tech businesses. The Company solves problems for the millions of customers of some of the world’s leading brands, by combining the best technology with compassionate service. With over 19,000 champion agents operating across eight strategic markets globally, Everise seeks to deliver happiness to customers of some of the world’s best loved brands. Our customer service solutions are high-performing, secure, and agile, with fluent proficiency in 32 languages, enabling businesses to scale globally while achieving top customer satisfaction. Learn more at www.weareeverise.com.

About Great Place to Work Certification™

Great Place To Work® Certification™ is the most definitive "employer-of-choice" recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.

About Great Place To Work®

As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List.

Learn more at greatplacetowork.com and follow Great Place To Work on LinkedIn, Twitter, Facebook and Instagram.

Source : Everise Triumphs in First-Time Great Place To Work Certification™

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network